Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Pharmacy Academy, Institute of Foreign Trade and Management University | India

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Shahbaz Khan’s academic journey reflects a strong commitment to pharmaceutical sciences, beginning with foundational studies in pharmacy and advancing through specialized postgraduate training in pharmacology. His scholarly dedication culminated in a doctoral degree in pharmaceutical sciences, where his research explored the phytochemical and pharmacological activities of Betula alnoides bark extracts. These early academic achievements not only provided him with a robust understanding of pharmacological principles but also shaped his future research interests in neuropharmacology, neuroscience, and inflammation studies.

Professional Endeavors

Dr. Khan’s professional career spans diverse academic and administrative roles in reputed institutions. He has served as a faculty member in both assistant and associate professor capacities, mentoring students at undergraduate, postgraduate, and doctoral levels. Alongside his teaching and research responsibilities, he has contributed significantly to institutional development through administrative positions such as hostel warden. His teaching philosophy combines rigorous academic training with practical exposure, ensuring that his students are well-prepared for the pharmaceutical and healthcare industries.

Contributions and Research Focus

Dr. Khan’s research portfolio is extensive and multidisciplinary, with particular emphasis on neuropharmacology, phytochemistry, and inflammation-related pathologies. His studies delve into the therapeutic potential of medicinal plants, the development of advanced drug delivery systems, and the role of nutraceuticals in managing neurodegenerative and chronic diseases. His work also encompasses nanomedicine, regenerative medicine, and targeted therapies, leading to innovations in formulations and biomedical applications. By integrating modern pharmacological techniques with traditional medicinal knowledge, he has made meaningful contributions to both preclinical research and applied therapeutic strategies.

Accolades and Recognition

Dr. Khan has earned multiple national and international honors that recognize his academic excellence and research contributions. His achievements include prestigious travel grants for participating in global scientific programs organized by international brain research organizations, as well as awards for specialized training in molecular neuropharmacology. These recognitions underscore his role as a scholar of global repute and his ability to represent Indian pharmaceutical research on international platforms.

Impact and Influence

The impact of Dr. Khan’s work extends beyond his own research, influencing students, collaborators, and the broader scientific community. His publications in high-impact journals have contributed to advancing knowledge in pharmacology, medicinal chemistry, and biomedical sciences. His patents and innovations in pharmaceutical formulations highlight his ability to bridge the gap between laboratory research and practical healthcare solutions. Through book authorship and editorial contributions, he has also enriched the academic resources available to scholars worldwide.

Legacy and Future Contributions

Dr. Khan’s legacy lies in his ability to combine teaching, research, and innovation into a cohesive professional identity. His mentorship has guided many students toward successful careers in pharmacy and research. Looking ahead, he aims to expand his research in neurotherapeutics, nanomedicine, and herbal pharmacology, with a focus on developing novel, safe, and effective treatments for neurological and inflammatory disorders. His future contributions are expected to further strengthen the role of pharmaceutical sciences in addressing global health challenges.

Publications

Exploring Betula alnoides Bark: Insilico and Preclinical Insights into its Antioxidant and Lipid-Lowering Effects in Hypercholesterolemia
Authors: Shahbaz Khan, Alka Lohani, Prashant Tiwari, Sunil Kumar Kadiri
Journal: Obesity Medicine
Year: 2025

Innovative nanomedicine for fungal infections: Advancing treatments through nanotechnology and mycological approaches
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: Journal of Drug Delivery Science and Technology
Year: 2025

Tailored polymeric hydrogels for regenerative medicine and drug delivery: From material design to clinical applications
Authors: Alka Lohani, Ritika Saxena, Joana Galvão Duarte, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: International Journal of Pharmaceutics
Year: 2025

pH-responsive IPN beads of carboxymethyl konjac glucomannan and sodium carboxymethyl cellulose as a controlled release carrier for ibuprofen
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Filipa Mascarenhas-Melo
Journal: International Journal of Biological Macromolecules
Year: 2024

An Insight Into Neuropathic Pain: A Systemic and Up-To-Date Review
Authors: Himanshu Sharma, Tanzeeb Rani, Shahbaz Khan
Journal: International Journal of Pharmaceutical Sciences and Research
Year: 2023

Conclusion

Through unwavering dedication to research, teaching, and innovation, Dr. Shahbaz Khan has established himself as a respected authority in pharmaceutical sciences. His contributions continue to inspire students, peers, and the scientific community at large, ensuring his place as a pivotal contributor to advancements in healthcare and pharmacology.

 

Annamaria Russo | Biochemistry, Genetics and Molecular Biology | Excellence in Research Award

Published on by Book of Award

Dr. Annamaria Russo | Biochemistry, Genetics and Molecular Biology | Excellence in Research Award

University of Messina | Italy

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Annamaria Russo embarked on her scientific journey with a degree in Biological Sciences from the University of Messina in 1997, graduating with top honors (110/110). Her experimental thesis on the functional properties of dolphin hemoglobin marked the beginning of a lifelong interest in comparative and clinical biochemistry. She earned her Professional Biologist Certification and later pursued a Ph.D. in Cellular Biology and Biotechnology in 2014, exploring the metabolic mechanisms and functionality of red blood cells through exogenous molecules.

👩‍🔬 Professional Endeavors

Dr. Russo's career has interwoven research, teaching, and academic mentorship. She began as a research fellow at the Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences (Chibiofaram), focusing on the structural and functional analysis of respiratory proteins in marine organisms. She also held postgraduate research positions in international institutions, including a notable stay at the Institute of Physiology at the Academy of Sciences in Prague. Parallel to her research, she has been a tenured mathematics and science teacher in several secondary schools in Sicily. Since 2006, she has held the title of “Cultore della Materia” in Biochemistry, consistently participating in exam boards and teaching activities.

🧪 Contributions and Research Focus

Dr. Russo's research focuses on biochemistry, erythrocyte metabolism, oxidative stress, protein-ligand interactions, and the thermodynamic characterization of blood components. She has extensively studied the Band 3 protein, hemoglobin functionalities, and interactions in both human and marine organisms. Her studies span from environmental biochemistry to medical applications, including research on red blood cells in diseases like ALS, sickle cell anemia, and the biochemical impact of COVID-19. Her research also explores natural antioxidant compounds and their role in protecting red blood cells, such as polyphenols and caffeine. Additionally, she has contributed to the development of bioplastics and biosensors for environmental applications.

🏅 Accolades and Recognition

With 43 scientific publications, 757 citations, and an H-index of 17, Dr. Russo has established herself as a respected voice in her field. She has served as an editorial board member for high-impact journals such as Stresses and Biology and has been a guest editor for thematic issues in journals like Antioxidants and IJMS (International Journal of Molecular Sciences). She also regularly reviews articles for prominent journals including Molecules and The Journal of Neuroscience Research.

Her research collaborations include prestigious institutions such as:

  • CNR (Rome, Milan, Messina)

  • Catholic University of the Sacred Heart

  • University of Palermo

  • University of Enna “Kore”

  • ARPACAL Calabria

  • University of Cassino

🌍 Impact and Influence

Dr. Russo has mentored numerous undergraduate and graduate students in laboratory settings and thesis projects, shaping the next generation of biochemists. Her work on erythrocyte metabolism and natural antioxidants has implications for clinical diagnostics, environmental monitoring, and neurodegenerative disease prevention. Her multidisciplinary collaborations have allowed her to bridge fundamental science with practical applications.

🔮 Legacy and Future Contributions

With ongoing research in the biochemical implications of environmental stressors, cell metabolism, and sustainable material development, Dr. Russo remains at the forefront of scientific innovation. Her latest conference presentations in 2025 on bioplastic sensors and biochemical characterization of metastasis underscore her commitment to translational research that benefits both health and the environment. Her legacy is that of a passionate scientist and educator dedicated to advancing knowledge in biochemistry while mentoring future scholars and contributing meaningfully to both academic and applied scientific communities.

Publications

📄 Epicatechin Influence on Biochemical Modification of Human Erythrocyte Metabolism and Membrane Integrity
Authors: Russo, Annamaria; Patanè, Giuseppe Tancredi; Laganá, Giuseppina; Tellone, Ester; Putaggio, Stefano
Journal: International Journal of Molecular Sciences
Year: 2024

📄 Crosstalk Between Sickle Cell Disease and Ferroptosis
Authors: Russo, Annamaria; Patanè, Giuseppe Tancredi; Calderaro, Antonella; Tellone, Ester; Putaggio, Stefano
Journal: International Journal of Molecular Sciences
Year: 2025

📄 Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols
Authors: Russo, Annamaria; Putaggio, Stefano; Tellone, Ester; Barreca, Davide; Patanè, Giuseppe Tancredi
Journal: Molecules
Year: 2025

📄 Canine and Human Red Blood Cells: Biochemical Mechanisms for the Control of Heat Dissipation
Authors: Russo, Annamaria; Patanè, Giuseppe Tancredi; Putaggio, Stefano; Barreca, Davide; Laganà, Giuseppina
Journal: Stresses
Year: 2024

Shinya Watanabe | Neuroscience | Best Research Award

Published on by Book of Award

Assist. Prof. Dr. Shinya Watanabe | Neuroscience | Best Research Award

University of Tsukuba | Japan 

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Dr. Shinya Watanabe’s academic journey began at Chiba University’s Department of Pharmaceutical Sciences. However, driven by a passion for medicine, he transitioned to the University of Tsukuba, earning a Bachelor’s degree in Medicine in 2005 and later a Ph.D. in Medicine in 2015. His diverse educational pursuits also include a specialized program in Medical Innovation Strategy at Chiba University, reflecting his commitment to integrating clinical expertise with innovative healthcare solutions.

Professional Endeavors 🩺

Dr. Watanabe’s illustrious medical career spans over two decades, marked by extensive hands-on experience across several leading hospitals in Japan. Starting as a resident at Tsukuba University Hospital, he later specialized as a neurosurgeon in institutions like Hitachi General Hospital and Tsukuba Medical Center. His tenure with the Pharmaceuticals and Medical Devices Agency (PMDA) between 2017 and 2020 saw him influencing drug, device, and regenerative medicine reviews, underscoring his role as a key figure in Japan’s medical regulatory landscape. Currently, he serves as a Lecturer at the University of Tsukuba’s Faculty of Medicine, contributing to both clinical practice and medical education.

Contributions and Research Focus 🔬

Dr. Watanabe’s research spans a variety of critical areas, including neurotrauma, cancer treatment, and dementia. His expertise has been certified by prestigious bodies such as the Japan Neurosurgical Society and the Japanese Society of Dementia. A thought leader in his field, Dr. Watanabe has actively developed innovative treatments, such as headache management techniques, and remains a sought-after expert in advancing medical technology and therapeutic strategies.

Accolades and Recognition 🏆

Dr. Watanabe’s exceptional contributions have been celebrated with numerous awards, such as the 12th Nose Award and the Research Encouragement Award from the Japanese Society for Diencephalo-Pituitary Tumors. In 2020, his groundbreaking interdisciplinary work earned him the Joyo Bank Award, highlighting his ability to bridge clinical practice with innovative technologies.

Impact and Influence 🌍

Through his extensive clinical and academic roles, Dr. Watanabe has shaped the practice of neurosurgery and medical device innovation in Japan. His contributions to the PMDA and ARO Council have had far-reaching effects, ensuring that healthcare products meet rigorous safety and efficacy standards. He has also inspired future generations of medical professionals through his dedication to education at the University of Tsukuba.

Legacy and Future Contributions 🌟

Dr. Watanabe’s legacy lies in his ability to blend clinical precision with innovation. As a pioneer in interdisciplinary research, he continues to push the boundaries of medical science, ensuring a brighter future for patients worldwide. His ongoing contributions to neuroscience, cancer treatment, and dementia care are set to redefine the standards of modern medicine, establishing him as a beacon of excellence in healthcare. With a career characterized by unwavering dedication and transformative achievements, Assist. Prof. Dr. Shinya Watanabe embodies the spirit of medical innovation and compassion.

 

Publications

📄"A Case of Idiopathic Intracranial Hypertension Complicated with both Infratentorial and Supratentorial Cortical Superficial Siderosis: Novel Imaging Findings on Intravoxel Incoherent Motion Magnetic Resonance Imaging Offering Clues to Pathophysiology"

  • Author: Watanabe, S.; Shibata, Y.; Ishikawa, E.
  • Journal: Neurology International
  • Year: 2024

📄"A Retrospective Cohort Study of Stereotactic Radiosurgery for Vestibular Schwannomas: Comparison of Two Age Groups (75 Years or Older vs. 65–74 Years)"

  • Author: Watanabe, S.; Yamamoto, M.; Aiyama, H.; Akutsu, H.; Ishikawa, E.
  • Journal: Surgical Neurology International
  • Year: 2024

📄"Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2024

📄"Empirical Myoelectric Feature Extraction and Pattern Recognition in Hemiplegic Distal Movement Decoding"

  • Author: Anastasiev, A.; Kadone, H.; Marushima, A.; Matsumaru, Y.; Ishikawa, E.
  • Journal: Bioengineering
  • Year: 2023

📄"Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials"

  • Author: Watanabe, S.; Nonaka, T.; Maeda, M.; Arakawa, Y.; Ishikawa, E.
  • Journal: Therapeutic Innovation and Regulatory Science
  • Year: 2023

 

Jialu Xu | Neuroscience | Best Researcher Award

Published on by Book of Award

Dr. Jialu Xu | Neuroscience | Best Researcher Award

Huazhong University of Science and Technology | China

Author Profile 

Orcid

Early Academic Pursuits 🎓

Dr. Jialu Xu has shown remarkable dedication to scientific research from early on in his academic journey. Having pursued a strong foundation in biomedical sciences, his commitment to understanding complex biological mechanisms has been evident through his involvement in various academic projects. His educational background at Huazhong University of Science and Technology laid the groundwork for his focus on biomedical research, particularly in the study of cognitive impairment and its underlying causes.

Professional Endeavors 💼

Dr. Xu is currently affiliated with Huazhong University of Science and Technology, where he actively contributes to research at Tongji Hospital. His work is interdisciplinary, spanning both clinical and laboratory settings. Dr. Xu's professional role has been instrumental in investigating the intricate pathways involved in cognitive diseases, where he collaborates with colleagues on cutting-edge research projects aimed at improving patient care and advancing scientific knowledge.

Contributions and Research Focus 🔬

One of Dr. Xu's most significant contributions is his study on how high-carbohydrate diets can lead to cognitive impairment. His research, published in Biomedicines in July 2024, demonstrates how these diets promote amyloid burden and tau phosphorylation through the PI3K/Akt/GSK-3β pathway in db/db mice. This groundbreaking work provides insights into the molecular mechanisms underlying neurodegenerative diseases like Alzheimer’s, opening doors to potential new therapeutic interventions. His research interests encompass neurology, metabolic disorders, and molecular pathways related to brain health.

Accolades and Recognition 🏆

Dr. Xu’s innovative research has garnered recognition in the scientific community. His recent publication in Biomedicines has been well-received, highlighting his growing reputation as a leader in cognitive impairment research. His work has contributed to expanding the knowledge base around neurodegenerative disorders and is recognized for its potential impact on future treatments.

Impact and Influence 🌍

Dr. Xu’s research not only influences the academic community but also has far-reaching implications for public health, especially in areas related to diet and neurodegenerative diseases. His findings on the impact of high-carbohydrate diets on cognitive health offer valuable guidance for clinicians and dieticians in developing preventive strategies and interventions for at-risk populations.

Legacy and Future Contributions 🌟

As Dr. Xu continues to expand his research, his future contributions are poised to significantly advance the understanding of cognitive diseases. His ongoing work will likely explore more innovative solutions to mitigate the effects of poor dietary habits on brain health. Dr. Xu’s legacy will be one of pioneering research that bridges the gap between molecular biology and practical health outcomes, ensuring his work leaves a lasting mark on the fields of neurology and dietary science.

 

Publications

📝 A High-Carbohydrate Diet Induces Cognitive Impairment and Promotes Amyloid Burden and Tau Phosphorylation via PI3K/Akt/GSK-3β Pathway in db/db Mice
Author: Jialu Xu; Lei Xie; Jiaxin Yin; Xiaoli Shi; Kun Dong; Jing Tao; Weijie Xu; Delin Ma; Shujun Zhang; Juan Chen et al.
Journal: Biomedicines
Year: 2024

 

Dong Hee Kim | Biochemistry, Genetics and Molecular Biology | Best Research Award

Published on by Book of Award

Dr. Dong Hee Kim | Biochemistry, Genetics and Molecular Biology | Best Research Award

Pusan national university | South Korea

Author Profile

Orcid

🎓 Early Academic Pursuits

Dr. Dong Hee Kim began his academic journey with a Bachelor of Science in Biology from the University of Ulsan, Korea, in 2004. He continued at the same institution for his M.S.-Ph.D. in Biological Sciences under the mentorship of Professor Byung Ju Lee, completing his doctorate in 2012. His thesis, "Studies on the role of NELL2 in neuroprotection and neural differentiation," laid the foundation for his future research endeavors.

💼 Professional Endeavors

Dr. Kim has held various prestigious positions throughout his career. He is currently a Research Fellow at Pusan National University Hospital since November 2022. Previously, he served as a Research Professor at the University of Ulsan from January 2019 to May 2022, and as a Research Fellow at the same university from January 2015 to October 2016. His early postdoctoral work was conducted at UNIST from March 2013 to December 2014.

🧪 Contributions and Research Focus

Dr. Kim's research primarily revolves around neuroprotection, neural differentiation, and the molecular mechanisms underlying neurodegenerative diseases. His notable grants include funding from WISET for studying the function of sodium-glucose cotransporter 2 (SGLT2) inhibitors in the brain, and multiple grants from the NRF of Korea, including studies on TonEBP function in hypothalamic leptin resistance and its role in degenerative brain disorders.

🏅 Accolades and Recognition

Throughout his career, Dr. Kim has received significant recognition for his contributions to biomedical research. His projects have been supported by prestigious grants, highlighting the impact and importance of his work in understanding brain functions and disorders. His research has also resulted in numerous publications in high-impact journals, further establishing his reputation in the field.

🌟 Impact and Influence

Dr. Kim's research has significantly advanced the understanding of neural mechanisms and their implications in neurodegenerative diseases. His work on the transcription regulation of key genes involved in brain function and inflammation has provided new insights into potential therapeutic targets. His publications have been widely cited, indicating the influence of his research on the scientific community.

📚 Legacy and Future Contributions

Dr. Kim's ongoing research continues to push the boundaries of our understanding of the brain. His current projects, funded by substantial grants, promise to uncover new mechanisms of brain function and disease. As he progresses in his career, Dr. Kim is poised to make further groundbreaking discoveries that will contribute to the field of biomedical science and technology.

 

Publications 📘

📄 Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Transcription Regulation of AgRP and POMC Genes

👩‍🔬 Authors: Kim DH*, Lee MJ, Kang D, Khang AR, Bae JH, Kim JY, Kim SH, Kang YH, Yi D.

📕 Journal: Curr Issues Mol Biol.

📅 Year: 2024

📄 Bridging Energy Need and Feeding Behavior: The Impact of eIF2α Phosphorylation in AgRP Neurons

👩‍🔬 Authors: Kim KK, Lee TH, Park BS, Kang D, Kim DH, Jeong B, Kim JW, Yang HR, Kim HR, Jin S, Back SH, Park JW, Kim JG, Lee BJ.

📕 Journal: Diabetes

📅 Year: 2023

📄 Sirtuin 1-Mediated Deacetylation of Hypothalamic TTF-1 Contributes to Energy Deficiency Response

👩‍🔬 Authors: Kang D, Yang HR, Kim DH, Kim KK, Jeong B, Park BS, Park JW, Kim JG, Lee BJ.

📕 Journal: Int J Mol Sci.

📅 Year: 2023

📄 Inhibition of LPAR1 Signaling in PDLSCs Reduces the Inflammatory Paracrine Effect on Primary Astrocyte Cells

👩‍🔬 Authors: Kim DH*, Seo EJ*, Kim YH, Jang IH.

📕 Journal: Int J Oral Biol.

📅 Year: 2022

📄 Transcriptional Regulatory Role of NELL2 in Preproenkphalin Gene Expression

👩‍🔬 Authors: Ha CM*, Kim DH*, Lee TH, Kim HR, Choi JI, Kim Y, Kang DS, Park JW, Oieda S, Jeong JK, Lee BJ.

📕 Journal: Mol Cells

📅 Year: 2022